Bay Adelaide Centre

SC2 Inc. Announces Amendments to Offer to Purchase Common Shares of Sherritt International Corporation

Retrieved on: 
Thursday, April 11, 2024
News, SC2, Suite, AB, Bay Adelaide Centre, Proxy, Adelaide Street, Speech, Letter, Knowledge, Reserve Square, Documentation, Canada Business Corporations Act, Telephone, Security (finance)

CALGARY, AB, April 10, 2024 /CNW/ - SC2 Inc. ("SC2") announced today that, in response to feedback from shareholders of Sherritt International Corporation ("Sherritt"), SC2 is varying its previously announced offer to acquire up to 21,621,621 common shares of Sherritt, at a price of $0.37 per common share (the "Offer"), by amending the expiry date of the Offer and the manner in which SC2 takes up and pays for those common shares.

Key Points: 
  • CALGARY, AB, April 10, 2024 /CNW/ - SC2 Inc. ("SC2") announced today that, in response to feedback from shareholders of Sherritt International Corporation ("Sherritt"), SC2 is varying its previously announced offer to acquire up to 21,621,621 common shares of Sherritt, at a price of $0.37 per common share (the "Offer"), by amending the expiry date of the Offer and the manner in which SC2 takes up and pays for those common shares.
  • No voting rights attached to common shares that have been tendered to the Offer will be exercised by SC2 until SC2 has taken up and paid for those common shares following the New Expiry Time.
  • If the Offer is withdrawn by SC2, SC2 shall cause all common shares delivered pursuant to the Offer to be returned to the shareholders.
  • Full details of the Offer are included in the Amended Letters, including complete instructions for the tendering and delivery of common shares to SC2.

SC2 Inc. Announces Offer to Purchase Common Shares of Sherritt International Corporation

Retrieved on: 
Tuesday, April 9, 2024
Letter, AB, Purchasing, Adelaide Street, SC2, Toronto Stock Exchange, Documentation, The Purchase Price, Proxy, Telephone, Knowledge, News, Suite, TSX, Canada Business Corporations Act, Offer, Reserve Square, Bay Adelaide Centre, Security (finance)

CALGARY, AB, April 8, 2024 /CNW/ - SC2 Inc. ("SC2") is pleased to announce an offer (the "Offer") to purchase up to 21,621,621 common shares of Sherritt International Corporation (TSX: S) ("Sherritt") at a price of $0.37 per common share (the "Purchase Price"), payable in cash.

Key Points: 
  • CALGARY, AB, April 8, 2024 /CNW/ - SC2 Inc. ("SC2") is pleased to announce an offer (the "Offer") to purchase up to 21,621,621 common shares of Sherritt International Corporation (TSX: S) ("Sherritt") at a price of $0.37 per common share (the "Purchase Price"), payable in cash.
  • If the Offer is withdrawn by SC2, SC2 shall cause all common shares delivered pursuant to the Offer to be returned to the shareholders.
  • Full details of the Offer are included in the Letters, including complete instructions for the tendering and delivery of common shares to SC2.
  • Deposited common shares may be withdrawn at any time prior to the time they are taken up by SC2.

10x Genomics Surpasses 100 Xenium Analyzer Shipments

Retrieved on: 
Tuesday, August 29, 2023
Tissue, Adelaide, University, FISH, Cancer Institute, Rosenbergia xenium, Genomics, Defence Research and Development Laboratory, Bay Adelaide Centre, 10x Genomics, Research, Research fellow, Genetic distance, RNA, Multiple sclerosis, Cell, H&E, Associate, IHC, Chemistry, Colorectal cancer, B cell, Professor, Data analysis, Melanoma, Icahn Genomics Institute, Biology, Basal-cell carcinoma, Growth, SNV, Health, Environment, Rest, MD Anderson Cancer Center, Gene, Disease, Medical imaging, Vaccine

PLEASANTON, Calif., Aug. 29, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has shipped more than 100 Xenium Analyzer instruments in the eight months since the platform's launch. The milestone reflects strong customer demand for the Xenium platform, which is increasingly recognized as the best performing system for in situ analysis.

Key Points: 
  • Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale
    PLEASANTON, Calif., Aug. 29, 2023 /PRNewswire/ -- 10x Genomics , Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has shipped more than 100 Xenium Analyzer instruments in the eight months since the platform's launch.
  • I firmly believe Xenium has the potential to be one of the most transformative technologies in our industry in decades."
  • With the vast majority of the first 100 Xenium shipments already installed, researchers are using the system to successfully analyze a variety of tissues and sample types, including fresh frozen, FFPE and tissue microarrays, and reveal new insights into health and disease.
  • Also in 2024, 10x Genomics expects to launch an in-line protein assay to combine with the RNA assays on the exact same tissue section.

Coinchange x Fasken to Host DeFi Educational Seminar for Cryptocurrency Users & Investors

Retrieved on: 
Monday, October 31, 2022
CEO, Google Play, Knowledge, GLOBE, Board, Industry, NFL Live, Decentralized finance, App Store (iOS/iPadOS), Lawyer, Ministry of National Education (France), Blockchain, App store, United Kingdom, Bay Adelaide Centre, Environment, Cryptocurrency

In attendance will be 100 guests including Coinchanges clients, partners, and investors, in addition to 20 individuals from Fasken.

Key Points: 
  • In attendance will be 100 guests including Coinchanges clients, partners, and investors, in addition to 20 individuals from Fasken.
  • Seminar speakers are Maxim Galash (CEO), Pratik Wagh (Research Analyst), and Lewis Bateman (Board Member), from Coinchange.
  • Everyone is encouraged to attend the seminar, especially those interested in the cryptocurrency markets and who want to learn more about DeFi.
  • Tickets for the educational seminar are now available free of charge, and users can now reserve their spots for whats set to be an exciting and informative event.

Enwave puts residual heat to work at Bay Adelaide Centre North

Retrieved on: 
Thursday, November 14, 2019
Energy, Articles, Brookfield Asset Management, Enwave, Municipal government of Toronto, OMERS, Energy recovery, PATH, Heat pump, Bay Adelaide Centre

For the North Tower, Enwave will build and operate within the Bay Adelaide Centre complex, a hot water plant that generates heat from both natural gas and electrically powered heat pumps, enhancing resiliency and optimizing energy use.

Key Points: 
  • For the North Tower, Enwave will build and operate within the Bay Adelaide Centre complex, a hot water plant that generates heat from both natural gas and electrically powered heat pumps, enhancing resiliency and optimizing energy use.
  • A supplemental heat pump will also capture residual heat from the DLWC system and reuse it to heat the building.
  • With this innovative system servicing Bay Adelaide Centre North Tower - Enwave continues to lead the industry by providing sustainable and highly-efficient low-carbon strategies for Torontos downtown core.
  • Carlyle Coutinho, President and Chief Operating Officer, Enwave Canada
    As the largest core-competency district energy provider in North America, Enwave Energy Corporation is an industry leader that provides innovative, sustainable energy solutions.